People · Operator

Cheri L. Walker

Named in public records as an officer, director or promoter · active 2015–2015 · Biotechnology

1
Companies
1
Filings
$19.9M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Kailos Genetics, Inc.BiotechnologySeed$19.9M$87.7M2015
Operator network

Cheri L. Walker at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Brian K. Pollock · 3 companies · 1 sharedBrian K. PollockJames R. Hudson, Jr. · 3 companies · 1 sharedJames R. Hudson, …David Troy Moore · 2 companies · 1 sharedDavid Troy MooreMichael J. Walters · 2 companies · 1 sharedMichael J. WaltersBrian Pollock · 1 companies · 1 sharedBrian PollockCheri R. Walker · 1 companies · 1 sharedCheri R. WalkerDanny C Windham · 1 companies · 1 sharedDanny C WindhamDanny R. Windham · 1 companies · 1 sharedDanny R. WindhamJames C Hudson · 1 companies · 1 sharedJames C HudsonKatherine T. Varley · 1 companies · 1 sharedKatherine T. Varl…Kenneth C Noonan · 1 companies · 1 sharedKenneth C NoonanKenneth R. Noonan · 1 companies · 1 sharedKenneth R. NoonanRandall C. Bachmeyer · 1 companies · 1 sharedRandall C. Bachme…Kailos Genetics, Inc. · $19.9M raisedKailos Genetics, Inc.Cheri L. WalkerCW
Cheri L. Walker Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Cheri L. Walker on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Brian K. Pollock13
James R. Hudson, Jr.13
Michael J. Walters12
David Troy Moore12
Brian Pollock11
Danny C Windham11
Kenneth C Noonan11
Danny R. Windham11
Kenneth R. Noonan11
Cheri R. Walker11
Katherine T. Varley11
Randall C. Bachmeyer11
James C Hudson11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.